Spatially Resolved Banff Tubulitis and Glomerulitis Scoring in Kidney Allograft Biopsies via Artificial Intelligent -Based Structure Segmentation and Spatial Transcriptomics

preprint OA: closed
Full text JSON View at publisher
Full text 1,964 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Abstract

Background Tubulitis is a defining histologic feature of T cell-mediated rejection (TCMR), while glomerulitis is often characteristic of antibody mediated rejection (AMR). Histologic quantification of tubulitis and glomerulitis using Banff criteria is subject to interobserver variability. Bulk transcriptomic assays (e.g., MMDx) have introduced molecular correlations of tubulitis with TCMR and glomerulitis with AMR, but lack spatial resolution.

Methods

We applied a web-based platform, FUSION (Functional Unit State Identification in Whole Slide Images), to a cohort of 8 cases (n=2 per condition) with kidney allograft biopsy samples acute TCMR, active AMR, chronic active AMR, and no rejection (control). The machine-learning (ML) platform enabled integrated visualization and analysis of spatial transcriptomics (10x Genomics Visium v2) together with high-resolution whole-slide histology.

Results

Transcriptomics-derived immune cell proportions within AI-segmented tubular and glomerular regions were used to generate spatial Banff t- and g-scores. Derived t-scores showed full concordance with pathologist scores in both acute TCMR cases; g-scores showed concordance in 2 of 4 AMR cases, with discordant cases characterized by low absolute immune signal near the classification boundary.

Conclusions

We demonstrate the feasibility of using AI-based FTU segmentation integrated with spatial transcriptomics-derived immune cell proportions to generate spatially informed t- and g-scores aligned with Banff criteria, with full concordance in severe rejection and partial concordance in mild rejection. This approach lays the foundation for validated, spatial transcriptomics-augmented t-scores and g-scores that enhance diagnostic precision, reduces inter-observer variability among renal pathologists, and support potential clinical adoption. Competing Interest Statement The authors have declared no competing interest. Footnotes ↵* Co-last authors

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00